At what point in the drug development process can a product launch occur?

At what point in the drug development process can a product launch occur?

• A. Preclinical
• B. Phase I
• C. Regulatory approval
• D. Post-marketing

Answer: (C)

The ability to launch a drug commercially comes after regulatory approval. This approval is the formal authorization from the regulatory authority that the evidence shows the benefits for the approved use outweigh the risks, and that manufacturing, labeling, and quality standards are met. Preclinical work and early clinical trials (safety and dosing data) are conducted to build the case for approval, but they do not authorize marketing. Post-marketing activities occur after the product is launched and focus on ongoing safety monitoring and real-world effectiveness. Some expedited pathways can speed access in certain cases, but the standard rule is that launch follows regulatory approval.

The ability to launch a drug commercially comes after regulatory approval. This approval is the formal authorization from the regulatory authority that the evidence shows the benefits for the approved use outweigh the risks, and that manufacturing, labeling, and quality standards are met. Preclinical work and early clinical trials (safety and dosing data) are conducted to build the case for approval, but they do not authorize marketing. Post-marketing activities occur after the product is launched and focus on ongoing safety monitoring and real-world effectiveness. Some expedited pathways can speed access in certain cases, but the standard rule is that launch follows regulatory approval.